Termitomycamide B manufacturers
|
| | Termitomycamide B Basic information |
| Product Name: | Termitomycamide B | | Synonyms: | Termitomycamide B;(9Z,12Z)-N-[2-(1H-indol-2-yl)-2-oxoethyl]octadeca-9,12-dienamide;9,12-Octadecadienamide, N-[2-(1H-indol-2-yl)-2-oxoethyl]-, (9Z,12Z)- | | CAS: | 1254277-89-8 | | MF: | C28H40N2O2 | | MW: | 436.63 | | EINECS: | | | Product Categories: | | | Mol File: | 1254277-89-8.mol |  |
| | Termitomycamide B Chemical Properties |
| Boiling point | 650.4±50.0 °C(Predicted) | | density | 1.030±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 20 mg/ml; DMSO: 20 mg/ml | | form | A crystalline solid | | pka | 14.57±0.46(Predicted) |
| | Termitomycamide B Usage And Synthesis |
| Description | Endoplasmic reticulum (ER) stress, caused by accumulation of misfolded proteins and a disruption of calcium homeostasis, has been linked to several neuronal diseases including, Parkinson’s, Alzheimer’s, and prion diseases. A screen for protective activity against ER stress-dependent cell death identified termitomycamides, extracts from the fruiting bodies of T. titanicus, a notably large edible mushroom that is cultivated symbiotically in the nests of termites Termitomycamide B is a fatty acid isolated from T. titanicus that at a dose of 0.1 μg/ml protects against ER stress-dependent cell death in Neuro2a cells induced by tunicamycin. | | Uses | Termitomycamide B (compound 2) is a neuroprotective agent that can be obtained from Termitomyces titanicus. Termitomycamide B effectively inhibits endoplasmic reticulum stress-dependent cell death. Termitomycamide B can be used in the study of neurodegenerative diseases[1][2]. | | References | [1] Choi JH, et al. Termitomycamides A to E, fatty acid amides isolated from the mushroom Termitomyces titanicus, suppress endoplasmic reticulum stress. Org Lett. 2010 Nov 5;12(21):5012-5. DOI:10.1021/ol102186p
[2] Yadav SK, et al. A Mechanistic Review on Medicinal Mushrooms-Derived Bioactive Compounds: Potential Mycotherapy Candidates for Alleviating Neurological Disorders. Planta Med. 2020 Nov;86(16):1161-1175. DOI:10.1055/a-1177-4834 |
| | Termitomycamide B Preparation Products And Raw materials |
|